Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 01, 2026 08:30 ET | Source: BioMedWire

How Advanced Drug Delivery Could Improve Existing Cancer Treatments

AUSTIN, Texas, June 01, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: As oncology drug-development costs continue climbing and regulatory pathways become increasingly complex,...
June 01, 2026 08:30 ET | Source: AINewsWire

AI’s Power Crisis Is Accelerating a Potential $2.5 Trillion Hydrogen Market

This article has been disseminated on behalf of MAX Power Mining Corp. and may include a paid advertisement. AUSTIN, Texas, June 01, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage:...
June 01, 2026 08:15 ET | Source: Jiuzi Holdings Inc.

Jiuzi Holdings Announces AI Intelligent Imaging Platform Achieves Milestone Progress and Advances Toward Commercial Deployment as Planned

Hangzhou, June 01, 2026 (GLOBE NEWSWIRE) -- Jiuzi Holdings, Inc. (Nasdaq: JZXN) (“Jiuzi” or the “Company”) today announced the latest developments regarding its AI intelligent imaging and data...
June 01, 2026 08:12 ET | Source: PCCA

Compounding Award Recipients Celebrated at PCCA CONNEXT: Canadian Compounding Conference 2026

LONDON, ONTARIO, June 01, 2026 (GLOBE NEWSWIRE) -- PCCA recognized excellence in pharmacy compounding with the presentation of two annual awards during CONNEXT: Canadian Compounding Conference 2026,...
June 01, 2026 08:00 ET | Source: Solid Biosciences Inc.

Solid Biosciences to Participate at Upcoming Investor Conferences

CHARLESTOWN, Mass., June 01, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for...
June 01, 2026 08:00 ET | Source: Elicio Therapeutics Inc.

Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company’s AMP-DNA Adjuvant Technology

BOSTON, June 01, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies...
June 01, 2026 08:00 ET | Source: Aura Biosciences, Inc.

Aura Biosciences Announces Enrollment Completion in Phase 3 CoMpass Trial of Bel-sar in Early Choroidal Melanoma

Enrollment of 108 patients completed in the registration-enabling Phase 3 CoMpass trial Topline data from the 15-month primary endpoint expected in the second half of 2027 BOSTON, June 01, 2026 ...
June 01, 2026 08:00 ET | Source: SEALMINER

Bitdeer Launches SEALMINER DL1 Hydro Achieving 52.5 GH/s and 149 J/GH Power Efficiency

SINGAPORE, June 01, 2026 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company for AI and Bitcoin mining infrastructure,...
June 01, 2026 08:00 ET | Source: MBX Biosciences, Inc.

MBX Biosciences to Host Virtual Investor Event to Discuss Once-Weekly Canvuparatide Presentations at ENDO 2026

CARMEL, Ind., June 01, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel...
June 01, 2026 08:00 ET | Source: Aprea Therapeutics

Aprea Therapeutics Presents Updated Phase 1 Data on WEE1 Inhibitor APR-1051 at ASCO 2026, Demonstrating Early Monotherapy Activity and Manageable Tolerability in Advanced Solid Tumors

Presentation highlights early clinical activity from ACESOT-1051, including partial responses and stable disease in patients across multiple tumor typesManageable tolerability confirmed across...